Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.
Saved in:
| Title: | Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial. |
|---|---|
| Authors: | Clayton AH; University of Virginia Health System, PO Box 800623, Charlottesville, VA 22908-0623 ahc8v@virginia.edu., Tourian KA, Focht K, Hwang E, Cheng RF, Thase ME |
| Source: | The Journal of clinical psychiatry [J Clin Psychiatry] 2015 May; Vol. 76 (5), pp. 562-9. |
| Publication Type: | Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Print Cited Medium: Internet ISSN: 1555-2101 (Electronic) Linking ISSN: 01606689 NLM ISO Abbreviation: J Clin Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
